Research programme: autism and schizophrenia therapeutic - Retrophin
Latest Information Update: 23 Aug 2013
At a glance
- Originator Retrophin
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Autistic disorder; Schizophrenia
Most Recent Events
- 16 Aug 2013 Investigation in Schizophrenia in USA
- 16 Aug 2013 Investigation in Autistic disorder in USA